HARRISBURG — Frustrating wait
Waiting for a decision – or a review by federal regulators – frustrates advocates such as Stanley.
He predicts an FDA review would cost $300 million to $500 million for research, last seven to 12 years, and yield a drug that will cost patients $10,000 a month to use.
“We have a profit-care system, not a health care system,” Stanley said.
Parents of epileptic children say that’s too long and costly.
Three mothers testified before a state Senate committee Tuesday to describe the human costs of delay.
Deena Kenny, of Lehigh County, said the legal drugs given to her son turned the boy so homicidal that he repeatedly tried to kill her.
“This was due to an FDA-approved medication,” she said.